<!DOCTYPE html>
<html lang="en" dir="ltr">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="manifest" href="/manifest.json">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">

  <title>Brain Cancer (Glioblastoma): Information & Treatment | StopMyCancer</title>
  <meta name="description" content="Understanding brain cancer and glioblastoma. Including symptoms, diagnosis, surgery, radiation, chemotherapy, and emerging therapies for primary brain tumors.">
  <meta name="keywords" content="brain cancer, glioblastoma, GBM, astrocytoma, IDH mutation, temozolomide, radiation therapy, tumor treating fields">
  <meta name="author" content="StopMyCancer">
  <link rel="canonical" href="https://stopmycancer.com/cancers/brain/">

  <meta property="og:type" content="article">
  <meta property="og:title" content="Brain Cancer (Glioblastoma): Information & Treatment">
  <meta property="og:description" content="Comprehensive guide to brain cancer, glioblastoma, and treatment options.">
  <meta property="og:url" content="https://stopmycancer.com/cancers/brain/">
  <meta property="og:site_name" content="StopMyCancer">
  <meta property="og:locale" content="en_US">
  <meta property="og:locale:alternate" content="es_ES">
  <meta property="og:locale:alternate" content="fr_FR">

  <link rel="alternate" hreflang="en" href="https://stopmycancer.com/cancers/brain/">
  <link rel="alternate" hreflang="es" href="https://stopmycancer.com/es/cancers/brain/">
  <link rel="alternate" hreflang="fr" href="https://stopmycancer.com/fr/cancers/brain/">

  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
  <link rel="stylesheet" href="/css/styles.css">
  <link rel="icon" type="image/svg+xml" href="data:image/svg+xml,<svg xmlns='http://www.w3.org/2000/svg' viewBox='0 0 100 100'><text y='.9em' font-size='90'>üõ°Ô∏è</text></svg>">

  <script type="application/ld+json">
  {
    "@context": "https://schema.org",
    "@type": "MedicalCondition",
    "name": "Glioblastoma (Brain Cancer)",
    "url": "https://stopmycancer.com/cancers/brain/",
    "description": "Glioblastoma is the most common and aggressive primary brain tumor in adults.",
    "possibleTreatment": [
      { "@type": "MedicalProcedure", "name": "Craniotomy (surgical resection)" },
      { "@type": "MedicalProcedure", "name": "Radiation Therapy" },
      { "@type": "MedicalProcedure", "name": "Chemotherapy (Temozolomide)" },
      { "@type": "MedicalProcedure", "name": "Tumor Treating Fields (TTF)" },
      { "@type": "MedicalProcedure", "name": "Immunotherapy" }
    ],
    "riskFactor": [
      "Prior radiation to the head",
      "Neurofibromatosis",
      "Tuberous sclerosis",
      "Li-Fraumeni syndrome"
    ]
  }
  </script>
</head>
<body>

  <a href="#main" class="skip-link">Skip to main content</a>

  <header class="header" role="banner">
    <div class="header__inner">
      <a href="/" class="header__logo" aria-label="StopMyCancer Home">
        <div class="header__logo-icon" aria-hidden="true">S</div>
        Stop<span>My</span>Cancer
      </a>

      <nav class="header__nav" role="navigation" aria-label="Main navigation">
        <a href="/cancers/" class="header__nav-link">Cancer Types</a>
        <a href="/navigate/" class="header__nav-link">Navigate</a>
        <a href="/stories/" class="header__nav-link">Stories</a>
        <a href="/access/" class="header__nav-link">Access &amp; Equity</a>
        <a href="/tools/pathology-translator" class="header__nav-link">Translator Tool</a>
        <a href="/about/" class="header__nav-link">About</a>
      </nav>

      <div class="header__actions">
        <div class="lang-switcher">
          <button class="lang-switcher__btn" aria-haspopup="true" aria-expanded="false" aria-label="Change language">
            <svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><circle cx="12" cy="12" r="10"></circle><line x1="2" y1="12" x2="22" y2="12"></line><path d="M12 2a15.3 15.3 0 0 1 4 10 15.3 15.3 0 0 1-4 10 15.3 15.3 0 0 1-4-10 15.3 15.3 0 0 1 4-10z"></path></svg>
            EN
            <svg width="12" height="12" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M6 9l6 6 6-6"></path></svg>
          </button>
          <div class="lang-switcher__dropdown" role="menu">
            <a href="/cancers/brain/" class="lang-switcher__option lang-switcher__option--active" role="menuitem">English</a>
            <a href="/es/cancers/brain/" class="lang-switcher__option" role="menuitem">Espa√±ol</a>
            <a href="/fr/cancers/brain/" class="lang-switcher__option" role="menuitem">Fran√ßais</a>
          </div>
        </div>

        <button class="mobile-toggle" aria-label="Open menu" aria-expanded="false" aria-controls="mobile-nav">
          <span class="mobile-toggle__line"></span>
          <span class="mobile-toggle__line"></span>
          <span class="mobile-toggle__line"></span>
        </button>
      </div>
    </div>
  </header>

  <nav class="mobile-nav" id="mobile-nav" role="navigation" aria-label="Mobile navigation">
    <a href="/cancers/" class="mobile-nav__link">Cancer Types</a>
    <a href="/navigate/" class="mobile-nav__link">Navigate</a>
    <a href="/stories/" class="mobile-nav__link">Stories</a>
    <a href="/access/" class="mobile-nav__link">Access &amp; Equity</a>
    <a href="/tools/pathology-translator" class="mobile-nav__link">Pathology Translator</a>
    <a href="/about/" class="mobile-nav__link">About</a>
    <div class="mobile-nav__lang">
      <div class="mobile-nav__lang-title">Language</div>
      <div class="mobile-nav__lang-options">
        <a href="/cancers/brain/" class="mobile-nav__lang-btn mobile-nav__lang-btn--active">EN</a>
        <a href="/es/cancers/brain/" class="mobile-nav__lang-btn">ES</a>
        <a href="/fr/cancers/brain/" class="mobile-nav__lang-btn">FR</a>
      </div>
    </div>
  </nav>

  <main id="main">

    <section class="page-header">
      <div class="container">
        <div class="breadcrumbs" role="navigation" aria-label="Breadcrumbs">
          <a href="/">Home</a> <span aria-hidden="true">/</span> <a href="/cancers/">Cancer Types</a> <span aria-hidden="true">/</span> <span>Brain Cancer</span>
        </div>
        <h1>Brain Cancer (Glioblastoma)</h1>
        <p class="page-header__subtitle">Understanding glioblastoma and primary brain tumors. Symptoms, diagnosis, surgery, radiation, chemotherapy, and newer treatments.</p>
      </div>
    </section>

    <section class="main-content">
      <div class="container">
        <div class="grid grid--content-sidebar">

          <article class="article">

            <section class="summary">
              <p><strong>Glioblastoma (GBM) is the most common and aggressive primary brain tumor in adults.</strong> While the prognosis has historically been poor, multimodal treatment (surgery, radiation, chemotherapy, and emerging therapies) and newer technologies like tumor treating fields (TTF) are improving outcomes. This is a serious diagnosis requiring multidisciplinary care at a specialized center.</p>
            </section>

            <section>
              <h2>What Is Brain Cancer?</h2>
              <p>Brain tumors originate from brain cells (not metastases from other cancers). Glioblastoma arises from glial cells (astrocytes), which support and protect neurons. It's a grade IV (highest grade) tumor, meaning it grows and spreads rapidly.</p>
              <p><strong>Key fact:</strong> Glioblastoma can be primary (develops from scratch) or secondary (from lower-grade glioma that progresses). Molecular markers (IDH mutation status, MGMT methylation, TP53) increasingly guide treatment.</p>
            </section>

            <section>
              <h2>Types of Brain Tumors</h2>
              <ul>
                <li><strong>Glioblastoma (Grade IV astrocytoma):</strong> Most aggressive. Requires maximum safe surgery, radiation, and chemotherapy.</li>
                <li><strong>Lower-grade gliomas (Grade II-III):</strong> Slower growing but still serious. Treatment depends on grade and molecular features.</li>
                <li><strong>Other primary brain tumors:</strong> Meningiomas, ependymomas, medulloblastomas (mostly pediatric). Each has different prognosis and treatment.</li>
              </ul>
            </section>

            <section>
              <h2>Risk Factors</h2>
              <ul>
                <li><strong>Prior head radiation:</strong> Most well-established risk factor.</li>
                <li><strong>Genetic syndromes:</strong> Neurofibromatosis type 1, tuberous sclerosis, Li-Fraumeni syndrome increase risk.</li>
                <li><strong>Age:</strong> Can occur at any age; glioblastoma peaks in 45-70 year-olds.</li>
                <li><strong>Immunosuppression:</strong> HIV+ individuals have higher risk.</li>
              </ul>
              <p><strong>Note:</strong> Despite popular misconception, cell phone use is not established as a risk factor.</p>
            </section>

            <section>
              <h2>Symptoms</h2>
              <p>Symptoms depend on tumor location and size. Common symptoms include:</p>
              <ul>
                <li>Persistent headaches (often morning headaches)</li>
                <li>Seizures (20-40% of patients)</li>
                <li>Vision or speech problems</li>
                <li>Balance or coordination difficulty (ataxia)</li>
                <li>Numbness or weakness (often on one side)</li>
                <li>Cognitive changes (memory, concentration)</li>
                <li>Nausea and vomiting</li>
                <li>Personality changes or behavioral changes</li>
              </ul>
              <p><strong>Important:</strong> Symptoms depend on tumor location. A small tumor in a critical area may cause more symptoms than a large tumor elsewhere.</p>
            </section>

            <section>
              <h2>Diagnosis</h2>
              <p><strong>Diagnostic tools:</strong></p>
              <ul>
                <li><strong>MRI with contrast:</strong> Gold standard. Shows tumor location, size, and extent.</li>
                <li><strong>CT scan:</strong> May show calcifications or bone involvement.</li>
                <li><strong>Biopsy or surgical resection:</strong> Only way to definitively diagnose and grade tumor. Often done during surgery.</li>
                <li><strong>Molecular testing:</strong> IDH status, MGMT methylation, TP53 mutation, EGFR amplification guide prognosis and treatment.</li>
              </ul>
            </section>

            <section>
              <h2>Staging &amp; Grading</h2>
              <p>Brain tumors use WHO grading (I-IV) rather than typical TNM staging:</p>
              <ul>
                <li><strong>Grade I-II:</strong> Low-grade, slower growing.</li>
                <li><strong>Grade III:</strong> Intermediate (anaplastic astrocytoma).</li>
                <li><strong>Grade IV:</strong> Glioblastoma, most aggressive, rapid growth.</li>
              </ul>
              <p>IDH-mutant tumors have better prognosis than IDH-wildtype tumors.</p>
            </section>

            <section>
              <h2>Treatment Options</h2>

              <h3>Maximal Safe Surgical Resection</h3>
              <p>Removing as much tumor as possible while preserving brain function. Intraoperative monitoring and imaging (awake craniotomy, neuronavigation) maximize resection while minimizing deficits. Extent of resection correlates with survival.</p>

              <h3>Radiation Therapy</h3>
              <p>Standard therapy post-surgery. Focal radiation to tumor and margin. Typical dose 60 Gray over 6 weeks. Newer techniques (IMRT, proton therapy) focus dose on tumor while sparing normal brain.</p>

              <h3>Chemotherapy</h3>
              <p><strong>Temozolomide (TMZ):</strong> Standard chemotherapy during and after radiation. Oral medication, generally well tolerated. Given concurrently with radiation, then adjuvant cycles.</p>

              <h3>Tumor Treating Fields (TTF)</h3>
              <p>FDA-approved device (Optune) that delivers electric fields to tumor. Worn as head cap. Used with chemotherapy. Improves progression-free and overall survival.</p>

              <h3>Immunotherapy &amp; Investigational Approaches</h3>
              <p>Checkpoint inhibitors and CAR-T therapy are under investigation. Some trials showing promise; not yet standard but increasingly available.</p>

              <h3>Supportive Care</h3>
              <p>Antiepileptic drugs (if seizures), corticosteroids (reduce brain swelling), anticoagulation (if blood clots), rehabilitation (physical/speech therapy).</p>
            </section>

            <section>
              <h2>Side Effects &amp; Survivorship</h2>
              <p><strong>From surgery:</strong> Temporary or permanent neurological deficits (weakness, speech changes, cognitive changes), hemorrhage, infection.</p>
              <p><strong>From radiation:</strong> Fatigue, hair loss (localized), cognitive decline (may be delayed, months to years later), radiation necrosis (tissue damage), secondary malignancy (rare but possible).</p>
              <p><strong>From chemotherapy:</strong> Nausea, bone marrow suppression, liver/kidney toxicity.</p>
              <p><strong>Long-term:</strong> Cognitive impairment is common (from tumor, surgery, and radiation). Neuropsychological rehabilitation, occupational therapy, and support are important.</p>
            </section>

            <section>
              <h2>Prognosis</h2>
              <p>Glioblastoma has serious prognosis, but has improved over time:</p>
              <ul>
                <li><strong>Median overall survival:</strong> 12-15 months with standard treatment (surgery, radiation, TMZ).</li>
                <li><strong>With TTF:</strong> May extend to 16-20 months.</li>
                <li><strong>IDH-mutant glioblastoma:</strong> Better prognosis, median 3+ years.</li>
                <li><strong>Younger patients:</strong> Often have better outcomes than older patients.</li>
              </ul>
              <p>Long-term survivorship (5+ years) is possible but uncommon. Focus shifts to quality of life and maintaining function.</p>
            </section>

            <section class="urgent-box">
              <h2>Seek Immediate Care If You Experience:</h2>
              <ul>
                <li>New seizure activity or status epilepticus (prolonged seizure)</li>
                <li>Acute severe headache with fever or stiff neck (infection)</li>
                <li>Sudden severe neurological changes (weakness, vision loss, speech problems)</li>
                <li>Signs of brain herniation (altered consciousness, unequal pupils, herniation breathing pattern)</li>
              </ul>
            </section>

            <section>
              <h2>Key Questions for Your Doctor</h2>
              <ul>
                <li>What are my tumor's molecular features (IDH status, MGMT, TP53)?</li>
                <li>How much tumor can be safely resected?</li>
                <li>What is the extent of resection plan?</li>
                <li>What is my expected radiation and chemotherapy regimen?</li>
                <li>Am I a candidate for TTF (Optune)?</li>
                <li>Are there clinical trials available?</li>
                <li>What rehabilitation and cognitive support is available?</li>
                <li>What is my expected prognosis and survival estimate?</li>
              </ul>
            </section>

          </article>

        </div>
      </div>
    </section>

  </main>

  <footer class="footer">
    <div class="container">
      <div class="footer__content">
        <div class="footer__section">
          <h3>StopMyCancer</h3>
          <p>Your cancer. Explained. Supported. Navigated.</p>
        </div>
        <div class="footer__section">
          <h4>Navigation</h4>
          <ul>
            <li><a href="/cancers/">Cancer Types</a></li>
            <li><a href="/navigate/">Navigate</a></li>
            <li><a href="/stories/">Stories</a></li>
            <li><a href="/access/">Access &amp; Equity</a></li>
          </ul>
        </div>
        <div class="footer__section">
          <h4>Resources</h4>
          <ul>
            <li><a href="/tools/pathology-translator">Pathology Translator</a></li>
            <li><a href="/about/">About</a></li>
            <li><a href="https://github.com/fantravel1/stopmycancer" target="_blank">GitHub</a></li>
          </ul>
        </div>
      </div>
      <div class="footer__bottom">
        <p>&copy; 2025 StopMyCancer. Licensed under CC BY 4.0.</p>
      </div>
    </div>
  </footer>

  <script src="/js/main.js"></script>

</body>
</html>
